PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ets1
|
ENSMUSG00000032035.17 | Ets1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ets1 | mm39_v1_chr9_+_32607301_32607417 | 0.86 | 9.7e-22 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_126817475 | 45.14 |
ENSMUST00000106313.8
ENSMUST00000142356.3 |
Septin1
|
septin 1 |
chr7_-_126817639 | 44.01 |
ENSMUST00000152267.8
ENSMUST00000106314.8 |
Septin1
|
septin 1 |
chr19_-_4240984 | 27.34 |
ENSMUST00000045864.4
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr19_-_4241034 | 26.94 |
ENSMUST00000237495.2
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr7_-_126736979 | 25.74 |
ENSMUST00000049931.6
|
Spn
|
sialophorin |
chr19_+_4204605 | 25.28 |
ENSMUST00000061086.9
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr1_-_133617824 | 25.01 |
ENSMUST00000189524.2
ENSMUST00000169295.8 |
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr17_+_34808772 | 23.88 |
ENSMUST00000038244.15
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr17_+_34809132 | 23.36 |
ENSMUST00000173772.2
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr4_-_129467430 | 23.15 |
ENSMUST00000102596.8
|
Lck
|
lymphocyte protein tyrosine kinase |
chr7_+_126895463 | 21.86 |
ENSMUST00000106306.9
ENSMUST00000120857.8 |
Itgal
|
integrin alpha L |
chr7_+_126895423 | 21.21 |
ENSMUST00000117762.8
|
Itgal
|
integrin alpha L |
chr11_-_79414542 | 21.10 |
ENSMUST00000179322.2
|
Evi2b
|
ecotropic viral integration site 2b |
chr16_-_19801781 | 19.75 |
ENSMUST00000058839.10
|
Klhl6
|
kelch-like 6 |
chr7_+_24596806 | 19.66 |
ENSMUST00000003469.8
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chr4_-_63321591 | 18.81 |
ENSMUST00000035724.5
|
Akna
|
AT-hook transcription factor |
chr15_+_84208915 | 18.73 |
ENSMUST00000023074.9
|
Parvg
|
parvin, gamma |
chr7_+_126895531 | 18.44 |
ENSMUST00000170971.8
|
Itgal
|
integrin alpha L |
chr3_+_106393348 | 18.16 |
ENSMUST00000183271.2
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr1_+_171216480 | 17.76 |
ENSMUST00000056449.9
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr4_-_129452148 | 16.88 |
ENSMUST00000167288.8
ENSMUST00000134336.3 |
Lck
|
lymphocyte protein tyrosine kinase |
chr4_-_129452180 | 16.53 |
ENSMUST00000067240.11
|
Lck
|
lymphocyte protein tyrosine kinase |
chr3_-_89325594 | 16.06 |
ENSMUST00000029679.4
|
Cks1b
|
CDC28 protein kinase 1b |
chr7_-_83304698 | 16.05 |
ENSMUST00000145610.8
|
Il16
|
interleukin 16 |
chr11_-_99045894 | 15.96 |
ENSMUST00000103134.4
|
Ccr7
|
chemokine (C-C motif) receptor 7 |
chr11_-_52173391 | 15.85 |
ENSMUST00000086844.10
|
Tcf7
|
transcription factor 7, T cell specific |
chr11_-_106050724 | 15.72 |
ENSMUST00000064545.11
|
Limd2
|
LIM domain containing 2 |
chr1_-_138102972 | 15.68 |
ENSMUST00000195533.6
ENSMUST00000183301.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr1_-_138103021 | 15.55 |
ENSMUST00000182755.8
ENSMUST00000193650.2 ENSMUST00000182283.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr3_-_90603013 | 15.29 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr11_-_72441054 | 15.21 |
ENSMUST00000021154.7
|
Spns3
|
spinster homolog 3 |
chr9_+_51124983 | 14.91 |
ENSMUST00000034554.9
|
Pou2af1
|
POU domain, class 2, associating factor 1 |
chr9_-_44920899 | 14.76 |
ENSMUST00000102832.3
|
Cd3e
|
CD3 antigen, epsilon polypeptide |
chr10_+_127157784 | 14.73 |
ENSMUST00000219511.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr2_-_118558852 | 14.71 |
ENSMUST00000102524.8
|
Plcb2
|
phospholipase C, beta 2 |
chr13_+_55517545 | 14.58 |
ENSMUST00000063771.14
|
Rgs14
|
regulator of G-protein signaling 14 |
chr5_+_86219593 | 14.48 |
ENSMUST00000198435.5
ENSMUST00000031171.9 |
Stap1
|
signal transducing adaptor family member 1 |
chr6_-_124715618 | 14.35 |
ENSMUST00000171549.9
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr5_-_140986312 | 14.07 |
ENSMUST00000085786.7
|
Card11
|
caspase recruitment domain family, member 11 |
chr6_-_124715560 | 13.83 |
ENSMUST00000004377.15
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_-_124715542 | 13.77 |
ENSMUST00000174265.2
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr19_+_41017714 | 13.72 |
ENSMUST00000051806.12
ENSMUST00000112200.3 |
Dntt
|
deoxynucleotidyltransferase, terminal |
chr5_-_134643805 | 13.30 |
ENSMUST00000202085.2
ENSMUST00000036362.13 ENSMUST00000077636.8 |
Lat2
|
linker for activation of T cells family, member 2 |
chr11_+_61017573 | 13.15 |
ENSMUST00000010286.8
ENSMUST00000146033.8 ENSMUST00000139422.8 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chr11_+_33996920 | 13.14 |
ENSMUST00000052413.12
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chr14_+_51366512 | 13.03 |
ENSMUST00000095923.4
|
Rnase6
|
ribonuclease, RNase A family, 6 |
chr7_-_30119227 | 13.02 |
ENSMUST00000208740.2
ENSMUST00000075062.5 |
Hcst
|
hematopoietic cell signal transducer |
chr11_-_6470918 | 12.96 |
ENSMUST00000003459.4
|
Myo1g
|
myosin IG |
chr8_-_84769170 | 12.94 |
ENSMUST00000005601.9
|
Il27ra
|
interleukin 27 receptor, alpha |
chr11_+_103061905 | 12.77 |
ENSMUST00000042286.12
ENSMUST00000218163.2 |
Fmnl1
|
formin-like 1 |
chrX_+_47235313 | 12.73 |
ENSMUST00000033427.7
|
Sash3
|
SAM and SH3 domain containing 3 |
chr17_+_57586094 | 12.72 |
ENSMUST00000169220.9
ENSMUST00000005889.16 ENSMUST00000112870.5 |
Vav1
|
vav 1 oncogene |
chr11_+_33997114 | 12.56 |
ENSMUST00000109329.9
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chr6_+_48715971 | 12.55 |
ENSMUST00000054368.7
ENSMUST00000140054.3 ENSMUST00000204168.2 ENSMUST00000204408.2 |
Gimap1
Gm28053
|
GTPase, IMAP family member 1 predicted gene, 28053 |
chr8_-_72175949 | 12.54 |
ENSMUST00000125092.2
|
Fcho1
|
FCH domain only 1 |
chr6_+_48661503 | 12.48 |
ENSMUST00000067506.14
ENSMUST00000119575.8 ENSMUST00000121957.8 ENSMUST00000090070.6 |
Gimap4
|
GTPase, IMAP family member 4 |
chr10_+_127159609 | 12.45 |
ENSMUST00000069548.7
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr2_+_22664094 | 12.41 |
ENSMUST00000014290.15
|
Apbb1ip
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr10_+_127159568 | 12.35 |
ENSMUST00000219026.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr7_+_24607042 | 12.32 |
ENSMUST00000151121.2
|
Arhgef1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
chr6_-_48685108 | 12.31 |
ENSMUST00000126422.3
ENSMUST00000119315.2 ENSMUST00000053661.7 |
Gimap6
|
GTPase, IMAP family member 6 |
chr14_-_32907023 | 12.29 |
ENSMUST00000130509.10
ENSMUST00000061753.15 |
Wdfy4
|
WD repeat and FYVE domain containing 4 |
chr19_+_11495858 | 12.26 |
ENSMUST00000025580.10
|
Ms4a6b
|
membrane-spanning 4-domains, subfamily A, member 6B |
chr15_-_102140331 | 12.21 |
ENSMUST00000230652.2
ENSMUST00000127014.3 ENSMUST00000001327.11 |
Itgb7
|
integrin beta 7 |
chr16_-_75706161 | 12.21 |
ENSMUST00000114239.9
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr1_+_34511793 | 12.03 |
ENSMUST00000188972.3
|
Ptpn18
|
protein tyrosine phosphatase, non-receptor type 18 |
chr2_+_150412329 | 12.00 |
ENSMUST00000089200.3
|
Cst7
|
cystatin F (leukocystatin) |
chr1_+_130793406 | 11.96 |
ENSMUST00000038829.7
|
Fcmr
|
Fc fragment of IgM receptor |
chr9_+_55997246 | 11.92 |
ENSMUST00000059206.8
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chrX_-_100311824 | 11.92 |
ENSMUST00000033664.14
|
Il2rg
|
interleukin 2 receptor, gamma chain |
chr7_-_126391388 | 11.82 |
ENSMUST00000206570.2
|
Ppp4c
|
protein phosphatase 4, catalytic subunit |
chr4_+_130640436 | 11.75 |
ENSMUST00000151698.8
|
Laptm5
|
lysosomal-associated protein transmembrane 5 |
chr11_+_3239868 | 11.70 |
ENSMUST00000094471.10
ENSMUST00000110043.8 |
Patz1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr9_-_88613967 | 11.70 |
ENSMUST00000098486.4
|
Bcl2a1d
|
B cell leukemia/lymphoma 2 related protein A1d |
chr11_-_70128678 | 11.55 |
ENSMUST00000108575.9
|
0610010K14Rik
|
RIKEN cDNA 0610010K14 gene |
chr1_+_61017057 | 11.51 |
ENSMUST00000027162.12
ENSMUST00000102827.4 |
Icos
|
inducible T cell co-stimulator |
chr17_+_34311314 | 11.49 |
ENSMUST00000025192.8
|
H2-Oa
|
histocompatibility 2, O region alpha locus |
chr12_-_32258604 | 11.43 |
ENSMUST00000053215.14
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
chr11_+_72851989 | 11.41 |
ENSMUST00000163326.8
ENSMUST00000108485.9 ENSMUST00000021142.8 ENSMUST00000108486.8 ENSMUST00000108484.8 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr7_+_28140352 | 11.36 |
ENSMUST00000078845.13
|
Gmfg
|
glia maturation factor, gamma |
chr9_-_57743989 | 11.24 |
ENSMUST00000164010.8
ENSMUST00000171444.8 ENSMUST00000098686.4 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr12_-_32258331 | 11.23 |
ENSMUST00000220366.2
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
chr15_-_66432938 | 11.20 |
ENSMUST00000048372.7
|
Tmem71
|
transmembrane protein 71 |
chr19_-_11243530 | 11.09 |
ENSMUST00000169159.3
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr18_+_50164043 | 11.08 |
ENSMUST00000145726.2
ENSMUST00000128377.2 |
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chrX_-_7956682 | 11.07 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr6_+_48661477 | 11.05 |
ENSMUST00000118802.8
|
Gimap4
|
GTPase, IMAP family member 4 |
chr16_-_3794404 | 11.01 |
ENSMUST00000180200.8
|
Nlrc3
|
NLR family, CARD domain containing 3 |
chr3_+_87754057 | 10.90 |
ENSMUST00000107581.9
|
Sh2d2a
|
SH2 domain containing 2A |
chr2_+_24276616 | 10.90 |
ENSMUST00000166388.2
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr3_+_87754310 | 10.82 |
ENSMUST00000029709.7
|
Sh2d2a
|
SH2 domain containing 2A |
chr2_-_118558825 | 10.82 |
ENSMUST00000159756.2
|
Plcb2
|
phospholipase C, beta 2 |
chr12_-_32258469 | 10.79 |
ENSMUST00000085469.6
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
chr1_-_131127825 | 10.74 |
ENSMUST00000068564.15
|
Rassf5
|
Ras association (RalGDS/AF-6) domain family member 5 |
chr9_-_20864096 | 10.71 |
ENSMUST00000004202.17
|
Dnmt1
|
DNA methyltransferase (cytosine-5) 1 |
chr3_+_90511068 | 10.70 |
ENSMUST00000001046.7
|
S100a4
|
S100 calcium binding protein A4 |
chr15_-_66684442 | 10.66 |
ENSMUST00000100572.10
|
Sla
|
src-like adaptor |
chrX_+_106299484 | 10.65 |
ENSMUST00000101294.9
ENSMUST00000118820.8 ENSMUST00000120971.8 |
Gpr174
|
G protein-coupled receptor 174 |
chr11_-_70128712 | 10.56 |
ENSMUST00000108577.8
ENSMUST00000108579.8 ENSMUST00000021181.13 ENSMUST00000108578.9 ENSMUST00000102569.10 |
0610010K14Rik
|
RIKEN cDNA 0610010K14 gene |
chr7_+_28488380 | 10.52 |
ENSMUST00000209035.2
ENSMUST00000059857.8 |
Rinl
|
Ras and Rab interactor-like |
chr7_-_44180700 | 10.49 |
ENSMUST00000205506.2
|
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr12_-_114104740 | 10.48 |
ENSMUST00000103473.2
|
Ighv9-3
|
immunoglobulin heavy variable V9-3 |
chr11_+_117673107 | 10.48 |
ENSMUST00000050874.14
ENSMUST00000106334.9 |
Tmc8
|
transmembrane channel-like gene family 8 |
chr2_-_31973795 | 10.48 |
ENSMUST00000056406.7
|
Fam78a
|
family with sequence similarity 78, member A |
chr1_+_165616250 | 10.36 |
ENSMUST00000161971.8
ENSMUST00000187313.7 ENSMUST00000178336.8 ENSMUST00000005907.12 ENSMUST00000027849.11 |
Cd247
|
CD247 antigen |
chr15_+_103362195 | 10.32 |
ENSMUST00000047405.9
|
Nckap1l
|
NCK associated protein 1 like |
chr14_-_70412804 | 10.27 |
ENSMUST00000143393.2
|
Pdlim2
|
PDZ and LIM domain 2 |
chr9_-_22042930 | 10.18 |
ENSMUST00000213815.2
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr15_-_9529898 | 10.11 |
ENSMUST00000228782.2
ENSMUST00000003981.6 |
Il7r
|
interleukin 7 receptor |
chr3_+_130904000 | 10.10 |
ENSMUST00000029611.14
ENSMUST00000106341.9 ENSMUST00000066849.13 |
Lef1
|
lymphoid enhancer binding factor 1 |
chr11_-_115968373 | 10.09 |
ENSMUST00000174822.8
|
Unc13d
|
unc-13 homolog D |
chr2_+_90927053 | 10.01 |
ENSMUST00000132741.3
|
Spi1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr19_+_12775938 | 9.93 |
ENSMUST00000025601.8
|
Lpxn
|
leupaxin |
chr6_-_87473260 | 9.93 |
ENSMUST00000101197.9
|
Arhgap25
|
Rho GTPase activating protein 25 |
chr7_+_119393210 | 9.85 |
ENSMUST00000033218.15
ENSMUST00000106520.9 |
Rexo5
|
RNA exonuclease 5 |
chr1_+_152683627 | 9.82 |
ENSMUST00000027754.7
|
Ncf2
|
neutrophil cytosolic factor 2 |
chr17_-_52133594 | 9.81 |
ENSMUST00000129667.8
ENSMUST00000169480.8 ENSMUST00000148559.2 |
Satb1
|
special AT-rich sequence binding protein 1 |
chr7_-_44888532 | 9.79 |
ENSMUST00000033063.15
|
Cd37
|
CD37 antigen |
chr8_-_89362745 | 9.71 |
ENSMUST00000034087.9
|
Snx20
|
sorting nexin 20 |
chr17_+_47816042 | 9.63 |
ENSMUST00000183044.8
ENSMUST00000037333.17 |
Ccnd3
|
cyclin D3 |
chr7_+_16576978 | 9.61 |
ENSMUST00000086104.6
|
Prkd2
|
protein kinase D2 |
chr7_-_101899294 | 9.57 |
ENSMUST00000106923.2
ENSMUST00000098230.11 |
Rhog
|
ras homolog family member G |
chr4_-_122779698 | 9.56 |
ENSMUST00000069533.12
|
Cap1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr2_+_43638814 | 9.55 |
ENSMUST00000112824.8
ENSMUST00000055776.8 |
Arhgap15
|
Rho GTPase activating protein 15 |
chr5_-_65248927 | 9.53 |
ENSMUST00000043352.8
|
Tmem156
|
transmembrane protein 156 |
chr9_+_88838953 | 9.50 |
ENSMUST00000098485.4
|
Bcl2a1a
|
B cell leukemia/lymphoma 2 related protein A1a |
chr7_-_44888220 | 9.42 |
ENSMUST00000210372.2
ENSMUST00000209779.2 ENSMUST00000098461.10 ENSMUST00000211373.2 |
Cd37
|
CD37 antigen |
chr7_+_28140450 | 9.33 |
ENSMUST00000135686.2
|
Gmfg
|
glia maturation factor, gamma |
chr7_+_16576821 | 9.29 |
ENSMUST00000168093.9
|
Prkd2
|
protein kinase D2 |
chr17_+_47815968 | 9.21 |
ENSMUST00000182129.8
ENSMUST00000171031.8 |
Ccnd3
|
cyclin D3 |
chr17_-_34109513 | 9.18 |
ENSMUST00000173386.2
ENSMUST00000114361.9 ENSMUST00000173492.9 |
Kifc1
|
kinesin family member C1 |
chr17_+_33774681 | 9.17 |
ENSMUST00000087605.13
ENSMUST00000174695.2 |
Myo1f
|
myosin IF |
chr1_+_85577709 | 9.17 |
ENSMUST00000155094.8
ENSMUST00000054279.15 ENSMUST00000147552.8 ENSMUST00000153574.8 ENSMUST00000150967.8 |
Sp100
|
nuclear antigen Sp100 |
chr7_+_24069680 | 9.17 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr2_+_152689881 | 9.16 |
ENSMUST00000164120.8
ENSMUST00000178997.8 ENSMUST00000109816.8 |
Tpx2
|
TPX2, microtubule-associated |
chr1_+_85577766 | 9.15 |
ENSMUST00000066427.11
|
Sp100
|
nuclear antigen Sp100 |
chr1_+_135060431 | 9.15 |
ENSMUST00000187985.7
ENSMUST00000049449.11 |
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr11_+_101333238 | 9.14 |
ENSMUST00000107249.8
|
Rpl27
|
ribosomal protein L27 |
chr10_+_41352310 | 8.99 |
ENSMUST00000019967.16
ENSMUST00000119962.8 ENSMUST00000099934.11 |
Mical1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
chr11_+_117673198 | 8.97 |
ENSMUST00000117781.8
|
Tmc8
|
transmembrane channel-like gene family 8 |
chr17_+_47816074 | 8.93 |
ENSMUST00000183177.8
ENSMUST00000182848.8 |
Ccnd3
|
cyclin D3 |
chr7_+_126184108 | 8.93 |
ENSMUST00000039522.8
|
Apobr
|
apolipoprotein B receptor |
chr4_+_130640611 | 8.91 |
ENSMUST00000156225.8
ENSMUST00000156742.8 |
Laptm5
|
lysosomal-associated protein transmembrane 5 |
chr7_-_121732067 | 8.81 |
ENSMUST00000106469.8
ENSMUST00000063587.13 ENSMUST00000106468.7 ENSMUST00000098068.10 |
Palb2
|
partner and localizer of BRCA2 |
chr7_+_100145192 | 8.80 |
ENSMUST00000133044.3
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr11_+_101333115 | 8.79 |
ENSMUST00000077856.13
|
Rpl27
|
ribosomal protein L27 |
chr8_+_106412905 | 8.79 |
ENSMUST00000213019.2
|
Carmil2
|
capping protein regulator and myosin 1 linker 2 |
chr1_-_80643024 | 8.78 |
ENSMUST00000187774.7
|
Dock10
|
dedicator of cytokinesis 10 |
chr1_-_80642969 | 8.78 |
ENSMUST00000190983.7
ENSMUST00000191449.2 |
Dock10
|
dedicator of cytokinesis 10 |
chr16_-_48592319 | 8.74 |
ENSMUST00000239408.2
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr7_-_44888465 | 8.73 |
ENSMUST00000210078.2
|
Cd37
|
CD37 antigen |
chr16_+_36755338 | 8.73 |
ENSMUST00000023531.15
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
chr7_+_24602337 | 8.70 |
ENSMUST00000117796.8
ENSMUST00000047873.16 ENSMUST00000098683.11 ENSMUST00000206508.2 ENSMUST00000206028.2 |
Arhgef1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
chr6_-_129449739 | 8.69 |
ENSMUST00000112076.9
ENSMUST00000184581.3 |
Clec7a
|
C-type lectin domain family 7, member a |
chr1_-_54965470 | 8.66 |
ENSMUST00000179030.8
ENSMUST00000044359.16 |
Ankrd44
|
ankyrin repeat domain 44 |
chr5_+_97145533 | 8.66 |
ENSMUST00000112974.6
ENSMUST00000035635.10 |
Bmp2k
|
BMP2 inducible kinase |
chr10_+_79722081 | 8.65 |
ENSMUST00000046091.7
|
Elane
|
elastase, neutrophil expressed |
chrX_+_99669343 | 8.64 |
ENSMUST00000048962.4
|
Kif4
|
kinesin family member 4 |
chr11_-_16958647 | 8.61 |
ENSMUST00000102881.10
|
Plek
|
pleckstrin |
chr11_+_32483290 | 8.53 |
ENSMUST00000102821.4
|
Stk10
|
serine/threonine kinase 10 |
chr11_+_96355413 | 8.53 |
ENSMUST00000103154.11
ENSMUST00000100521.10 ENSMUST00000100519.11 |
Skap1
|
src family associated phosphoprotein 1 |
chr6_-_56681657 | 8.53 |
ENSMUST00000176595.3
ENSMUST00000170382.5 ENSMUST00000203958.2 |
Lsm5
|
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
chr16_-_48592372 | 8.49 |
ENSMUST00000231701.3
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr8_-_123159639 | 8.43 |
ENSMUST00000212600.2
|
Cyba
|
cytochrome b-245, alpha polypeptide |
chr9_-_20556031 | 8.41 |
ENSMUST00000148631.8
ENSMUST00000131128.2 ENSMUST00000151861.9 ENSMUST00000131343.8 ENSMUST00000086458.10 |
Fbxl12
|
F-box and leucine-rich repeat protein 12 |
chr7_-_128019874 | 8.40 |
ENSMUST00000145739.3
ENSMUST00000033133.12 |
Rgs10
|
regulator of G-protein signalling 10 |
chr16_+_19578981 | 8.35 |
ENSMUST00000079780.10
ENSMUST00000164397.8 |
B3gnt5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
chr11_+_96355441 | 8.27 |
ENSMUST00000071510.14
ENSMUST00000107662.9 |
Skap1
|
src family associated phosphoprotein 1 |
chr9_+_56325893 | 8.26 |
ENSMUST00000034879.5
ENSMUST00000215269.2 |
Hmg20a
|
high mobility group 20A |
chr15_+_78481247 | 8.24 |
ENSMUST00000043069.6
ENSMUST00000231180.2 ENSMUST00000229796.2 ENSMUST00000229295.2 |
Cyth4
|
cytohesin 4 |
chr9_+_21437440 | 8.24 |
ENSMUST00000086361.12
ENSMUST00000173769.3 |
AB124611
|
cDNA sequence AB124611 |
chrX_+_56257374 | 8.23 |
ENSMUST00000033466.2
|
Cd40lg
|
CD40 ligand |
chr9_+_56326089 | 8.14 |
ENSMUST00000213242.2
ENSMUST00000214771.2 ENSMUST00000217518.2 ENSMUST00000214869.2 |
Hmg20a
|
high mobility group 20A |
chr1_+_171668173 | 8.12 |
ENSMUST00000136479.8
|
Cd84
|
CD84 antigen |
chr17_+_47815998 | 8.08 |
ENSMUST00000183210.2
|
Ccnd3
|
cyclin D3 |
chr1_+_135060994 | 8.06 |
ENSMUST00000167080.3
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr9_+_89081262 | 8.01 |
ENSMUST00000068569.5
|
Bcl2a1b
|
B cell leukemia/lymphoma 2 related protein A1b |
chr17_-_52140305 | 8.00 |
ENSMUST00000133574.8
|
Satb1
|
special AT-rich sequence binding protein 1 |
chr13_-_17979675 | 8.00 |
ENSMUST00000223490.2
|
Cdk13
|
cyclin-dependent kinase 13 |
chr4_-_122779742 | 7.99 |
ENSMUST00000128485.2
|
Cap1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr10_-_93146825 | 7.99 |
ENSMUST00000151153.2
|
Elk3
|
ELK3, member of ETS oncogene family |
chr2_-_130021229 | 7.96 |
ENSMUST00000103199.9
|
Snrpb
|
small nuclear ribonucleoprotein B |
chr5_+_149121458 | 7.94 |
ENSMUST00000122160.8
ENSMUST00000100410.10 ENSMUST00000119685.8 |
Uspl1
|
ubiquitin specific peptidase like 1 |
chr17_+_35460722 | 7.89 |
ENSMUST00000068056.12
ENSMUST00000174757.8 ENSMUST00000173731.8 |
Ddx39b
|
DEAD box helicase 39b |
chr17_-_50401305 | 7.87 |
ENSMUST00000113195.8
|
Rftn1
|
raftlin lipid raft linker 1 |
chr14_-_122153185 | 7.85 |
ENSMUST00000055475.9
|
Gpr18
|
G protein-coupled receptor 18 |
chr3_-_106697459 | 7.85 |
ENSMUST00000038845.10
|
Cd53
|
CD53 antigen |
chr11_-_46203047 | 7.83 |
ENSMUST00000129474.2
ENSMUST00000093166.11 ENSMUST00000165599.9 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr8_+_4375212 | 7.83 |
ENSMUST00000127460.8
ENSMUST00000136191.8 |
Ccl25
|
chemokine (C-C motif) ligand 25 |
chr7_+_43086432 | 7.81 |
ENSMUST00000070518.4
|
Nkg7
|
natural killer cell group 7 sequence |
chr14_-_31216949 | 7.76 |
ENSMUST00000228181.2
ENSMUST00000227777.2 ENSMUST00000227595.2 ENSMUST00000228727.2 ENSMUST00000055303.5 |
Mettl6
|
methyltransferase like 6 |
chr12_-_114263874 | 7.74 |
ENSMUST00000103482.2
ENSMUST00000194159.2 |
Ighv9-4
|
immunoglobulin heavy variable 9-4 |
chr7_+_28682253 | 7.74 |
ENSMUST00000085835.8
|
Map4k1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr5_-_65248962 | 7.73 |
ENSMUST00000212080.2
|
Tmem156
|
transmembrane protein 156 |
chr9_-_57552392 | 7.73 |
ENSMUST00000216934.2
|
Csk
|
c-src tyrosine kinase |
chr2_+_152689913 | 7.72 |
ENSMUST00000028969.9
|
Tpx2
|
TPX2, microtubule-associated |
chr17_+_47816137 | 7.69 |
ENSMUST00000182935.8
ENSMUST00000182506.8 |
Ccnd3
|
cyclin D3 |
chr11_+_68322945 | 7.67 |
ENSMUST00000021283.8
|
Pik3r5
|
phosphoinositide-3-kinase regulatory subunit 5 |
chr9_-_57552844 | 7.66 |
ENSMUST00000216979.2
ENSMUST00000034863.8 |
Csk
|
c-src tyrosine kinase |
chr2_-_26250886 | 7.65 |
ENSMUST00000028294.7
|
Card9
|
caspase recruitment domain family, member 9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 25.7 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
8.2 | 73.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
8.0 | 16.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
7.8 | 31.2 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
6.9 | 20.7 | GO:0071846 | actin filament debranching(GO:0071846) |
5.8 | 52.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
5.6 | 16.9 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
5.3 | 42.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
5.1 | 66.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
5.1 | 15.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
4.2 | 33.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
3.9 | 3.9 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
3.8 | 11.5 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.8 | 19.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.7 | 11.1 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
3.7 | 11.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
3.6 | 25.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.5 | 14.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
3.4 | 20.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
3.3 | 9.9 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
3.3 | 3.3 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
3.2 | 13.0 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
3.2 | 6.4 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
3.2 | 6.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
3.2 | 47.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
3.1 | 27.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.1 | 15.5 | GO:0030576 | Cajal body organization(GO:0030576) |
3.1 | 15.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
3.0 | 9.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
2.9 | 8.8 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
2.9 | 28.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
2.9 | 8.6 | GO:0060305 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
2.8 | 11.4 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
2.8 | 28.3 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
2.8 | 8.4 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
2.8 | 5.6 | GO:0090135 | actin filament branching(GO:0090135) |
2.7 | 8.2 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
2.7 | 10.7 | GO:0090309 | C-5 methylation of cytosine(GO:0090116) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
2.6 | 7.9 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
2.4 | 7.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
2.4 | 9.7 | GO:0017126 | nucleologenesis(GO:0017126) |
2.4 | 7.2 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
2.4 | 11.9 | GO:1901355 | response to rapamycin(GO:1901355) |
2.4 | 9.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.4 | 4.7 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
2.3 | 44.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.3 | 9.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.3 | 6.8 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
2.3 | 9.0 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
2.2 | 55.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.2 | 6.6 | GO:0071163 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
2.1 | 17.1 | GO:0002432 | granuloma formation(GO:0002432) |
2.1 | 17.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.1 | 6.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
2.1 | 6.2 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
2.0 | 10.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.0 | 12.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
2.0 | 4.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
2.0 | 11.9 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.9 | 9.7 | GO:0002352 | B cell negative selection(GO:0002352) |
1.9 | 9.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.9 | 15.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.9 | 7.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
1.8 | 23.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.8 | 12.3 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
1.7 | 5.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
1.7 | 3.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.7 | 6.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.7 | 5.0 | GO:1904826 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
1.7 | 8.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.7 | 8.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.6 | 6.5 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.6 | 12.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.6 | 9.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.6 | 17.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.6 | 4.7 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
1.5 | 10.7 | GO:0060057 | negative regulation of translation in response to stress(GO:0032055) negative regulation of interleukin-1 beta secretion(GO:0050713) apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.5 | 4.5 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
1.5 | 28.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.5 | 4.5 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
1.5 | 22.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
1.5 | 7.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.5 | 5.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.5 | 2.9 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
1.4 | 12.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.4 | 5.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.4 | 7.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.4 | 2.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.4 | 6.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.3 | 6.7 | GO:0009597 | detection of virus(GO:0009597) |
1.3 | 5.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
1.3 | 1.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.3 | 5.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
1.3 | 12.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.3 | 5.0 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.2 | 13.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.2 | 12.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.2 | 3.7 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.2 | 4.9 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
1.2 | 2.4 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.2 | 6.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
1.2 | 4.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.2 | 6.0 | GO:0002507 | tolerance induction(GO:0002507) |
1.2 | 4.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.2 | 7.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
1.2 | 19.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.2 | 19.1 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.2 | 3.6 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
1.2 | 8.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.2 | 3.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.2 | 5.8 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.2 | 13.8 | GO:0051014 | actin filament severing(GO:0051014) |
1.1 | 25.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.1 | 5.7 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
1.1 | 2.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.1 | 6.6 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
1.1 | 14.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
1.1 | 6.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.1 | 8.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.1 | 6.5 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
1.1 | 5.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.1 | 4.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.1 | 1.1 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.0 | 3.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.0 | 4.1 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
1.0 | 20.7 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
1.0 | 16.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 6.1 | GO:1990839 | response to endothelin(GO:1990839) |
1.0 | 3.0 | GO:0043366 | beta selection(GO:0043366) |
1.0 | 29.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.0 | 2.0 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
1.0 | 83.6 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.0 | 28.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.0 | 3.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.0 | 6.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
1.0 | 4.8 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 8.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
1.0 | 14.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.0 | 4.8 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.9 | 3.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.9 | 5.6 | GO:0097531 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
0.9 | 2.8 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
0.9 | 0.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.9 | 7.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.9 | 3.7 | GO:1902276 | pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
0.9 | 3.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.9 | 3.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.9 | 17.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.9 | 4.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.9 | 18.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.9 | 2.7 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.9 | 6.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.9 | 2.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.9 | 3.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.9 | 6.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.9 | 4.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.9 | 6.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 6.0 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.9 | 2.6 | GO:0035874 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
0.9 | 6.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.9 | 4.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.8 | 2.5 | GO:0042262 | DNA protection(GO:0042262) dATP catabolic process(GO:0046061) |
0.8 | 2.5 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.8 | 3.2 | GO:0032079 | glucosylceramide catabolic process(GO:0006680) positive regulation of endodeoxyribonuclease activity(GO:0032079) positive regulation of phospholipid catabolic process(GO:0060697) |
0.8 | 2.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.8 | 2.4 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.8 | 2.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.8 | 7.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 2.3 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.8 | 2.3 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.8 | 2.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.8 | 4.6 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.8 | 15.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 3.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.8 | 3.0 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.8 | 12.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.8 | 26.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.7 | 4.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.7 | 5.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 2.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.7 | 16.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 2.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.7 | 10.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.7 | 1.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.7 | 2.2 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
0.7 | 2.9 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
0.7 | 2.8 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.7 | 17.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.7 | 1.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.7 | 4.2 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.7 | 7.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.7 | 4.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 9.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 5.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 1.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.7 | 1.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.7 | 5.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.7 | 11.5 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.7 | 25.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.7 | 2.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.7 | 1.3 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
0.7 | 2.0 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.6 | 27.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.6 | 17.2 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.6 | 7.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.6 | 7.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 1.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.6 | 8.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 1.9 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.6 | 4.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 13.8 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.6 | 1.9 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 3.8 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.6 | 1.9 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.6 | 5.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.6 | 2.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.6 | 1.8 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.6 | 2.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.6 | 8.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.6 | 4.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 2.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.6 | 3.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.6 | 2.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 5.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.6 | 13.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 1.7 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.6 | 5.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 1.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.6 | 5.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.6 | 2.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 5.6 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.6 | 5.0 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.6 | 5.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.6 | 1.7 | GO:0006059 | hexitol metabolic process(GO:0006059) glycolytic process from galactose(GO:0061623) |
0.5 | 2.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
0.5 | 8.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 3.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.5 | 4.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 6.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 3.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.5 | 7.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 1.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.5 | 2.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 3.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 3.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.5 | 5.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.5 | 2.5 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.5 | 2.0 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.5 | 2.4 | GO:1990743 | protein sialylation(GO:1990743) |
0.5 | 8.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.5 | 14.5 | GO:0033198 | response to ATP(GO:0033198) |
0.5 | 6.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 3.8 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 6.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.5 | 1.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.5 | 6.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 12.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 3.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.5 | 3.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 2.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 1.4 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.5 | 1.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 1.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 1.4 | GO:0046038 | GMP catabolic process(GO:0046038) |
0.5 | 16.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 14.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 3.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 3.1 | GO:0035633 | cyclooxygenase pathway(GO:0019371) maintenance of blood-brain barrier(GO:0035633) |
0.4 | 2.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 10.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.4 | 2.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.4 | 2.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.4 | 2.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 3.9 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.4 | 3.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 4.8 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 4.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 3.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 7.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 3.8 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.4 | 2.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 12.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 6.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.4 | 59.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 15.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.4 | 6.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.4 | 9.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.4 | 11.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 5.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 1.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 4.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.4 | 0.8 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 2.7 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.4 | 1.6 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.4 | 10.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 17.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 1.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 6.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 8.8 | GO:0042113 | B cell activation(GO:0042113) |
0.4 | 5.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 9.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 6.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 0.8 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.4 | 5.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 2.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 2.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 9.9 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.4 | 2.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 16.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.4 | 2.6 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.4 | 6.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 5.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.4 | 13.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.4 | 3.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.4 | 4.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.4 | 1.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.4 | 3.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.7 | GO:1902583 | intracellular transport of virus(GO:0075733) regulation of intracellular transport of viral material(GO:1901252) multi-organism intracellular transport(GO:1902583) |
0.3 | 3.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 3.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 1.7 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 10.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 1.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.3 | 3.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 3.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 1.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 9.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.3 | 10.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.3 | 1.0 | GO:0051030 | snRNA transport(GO:0051030) |
0.3 | 11.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.6 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 2.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 6.0 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.3 | 1.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.3 | 12.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 3.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.3 | 2.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 11.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 2.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 1.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.9 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.3 | 2.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 8.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.3 | 2.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 0.3 | GO:0097325 | regulation of collagen catabolic process(GO:0010710) melanocyte proliferation(GO:0097325) |
0.3 | 0.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.3 | 1.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 11.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.3 | 0.9 | GO:0034970 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) histone H3-R2 methylation(GO:0034970) |
0.3 | 2.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 5.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 3.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 1.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 13.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 12.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 1.4 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.5 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.3 | 7.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.3 | 8.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 1.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 2.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.3 | 2.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 3.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 4.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.8 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.3 | 1.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.3 | 3.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.5 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.2 | 11.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 2.9 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 18.8 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 3.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 1.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 1.6 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 1.6 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 21.9 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 7.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 4.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 16.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 2.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 3.8 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 13.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 2.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 3.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 3.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 1.1 | GO:2000584 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.2 | 0.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 2.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 5.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 1.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 1.4 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 | 3.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 2.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 2.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 2.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 1.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 2.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 2.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 1.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.2 | 0.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.2 | 6.1 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 13.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.2 | 2.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.2 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 14.1 | GO:0030217 | T cell differentiation(GO:0030217) |
0.2 | 2.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 5.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.7 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 3.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.0 | GO:0060298 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) positive regulation of sarcomere organization(GO:0060298) |
0.2 | 1.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 1.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 6.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 23.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 7.7 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 7.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 4.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 6.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.8 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 3.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 1.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 7.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 5.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 3.0 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 28.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 3.2 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.1 | 1.1 | GO:1903209 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.1 | 1.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 2.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 2.6 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 1.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.9 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 2.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 19.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 4.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.8 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.1 | 0.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 3.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 1.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 2.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 3.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 4.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 7.3 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.1 | 12.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 3.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.6 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.1 | 3.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 1.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 36.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 2.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 3.0 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 2.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 1.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 10.6 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 1.6 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.7 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 4.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 2.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.6 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 2.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 1.6 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 2.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 1.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.3 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 1.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 2.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 5.2 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 0.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 2.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 1.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 3.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 3.5 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.1 | 5.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 3.1 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.1 | 1.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 2.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 1.7 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 3.6 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 2.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 1.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.1 | 1.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 1.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 2.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 1.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 2.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 1.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 4.4 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 4.2 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 6.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 1.8 | GO:0097484 | dendrite extension(GO:0097484) |
0.0 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 1.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.4 | GO:0021684 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 1.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 2.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 1.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 1.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 1.9 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 1.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.6 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 1.0 | GO:0001656 | metanephros development(GO:0001656) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 1.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 61.5 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
8.6 | 25.7 | GO:0036398 | TCR signalosome(GO:0036398) |
8.1 | 40.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
6.4 | 25.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
5.9 | 70.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
3.6 | 71.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
3.5 | 24.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.0 | 42.7 | GO:0016589 | NURF complex(GO:0016589) |
2.9 | 20.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.9 | 14.6 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
2.7 | 8.1 | GO:1990031 | pinceau fiber(GO:1990031) |
2.7 | 8.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
2.6 | 13.0 | GO:0000799 | nuclear condensin complex(GO:0000799) |
2.4 | 9.6 | GO:0008623 | CHRAC(GO:0008623) |
2.4 | 12.0 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
2.2 | 6.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
2.2 | 34.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.1 | 107.4 | GO:0001772 | immunological synapse(GO:0001772) |
2.1 | 16.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.0 | 6.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
2.0 | 20.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.0 | 11.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.0 | 25.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 20.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.5 | 10.8 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 10.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.5 | 51.7 | GO:0031527 | filopodium membrane(GO:0031527) |
1.4 | 4.2 | GO:0034455 | t-UTP complex(GO:0034455) |
1.3 | 6.6 | GO:0017177 | glucosidase II complex(GO:0017177) |
1.3 | 8.8 | GO:0036396 | MIS complex(GO:0036396) |
1.2 | 10.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.2 | 8.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.2 | 3.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.2 | 15.7 | GO:0005818 | aster(GO:0005818) |
1.2 | 16.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.1 | 12.6 | GO:0005687 | U4 snRNP(GO:0005687) |
1.1 | 5.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
1.1 | 5.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.1 | 10.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.1 | 75.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.0 | 6.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.0 | 4.8 | GO:0005914 | spot adherens junction(GO:0005914) |
1.0 | 3.9 | GO:0042585 | germinal vesicle(GO:0042585) |
1.0 | 11.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.0 | 4.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.9 | 7.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.9 | 12.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 75.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 8.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.9 | 8.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.9 | 6.0 | GO:0089701 | U2AF(GO:0089701) |
0.8 | 10.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.8 | 10.0 | GO:0000801 | central element(GO:0000801) |
0.8 | 5.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 6.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.8 | 2.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.8 | 5.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.8 | 16.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.8 | 4.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.8 | 5.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.8 | 3.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.8 | 2.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.8 | 5.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 5.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.7 | 11.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.7 | 2.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 7.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 11.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 38.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.6 | 1.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.6 | 5.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 9.4 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 3.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 4.3 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.6 | 4.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.6 | 5.3 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 2.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 3.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.6 | 5.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 1.6 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.5 | 1.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.5 | 7.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 7.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 13.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 2.0 | GO:0036019 | endolysosome(GO:0036019) |
0.5 | 2.0 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 4.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.5 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 4.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 10.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 14.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.5 | 30.2 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 1.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.5 | 17.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.5 | 7.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 8.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 2.6 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 12.6 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.4 | 2.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 29.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 10.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 4.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 5.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 52.8 | GO:0016605 | PML body(GO:0016605) |
0.4 | 3.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 2.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 4.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 4.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 3.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 4.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 42.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.4 | 2.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 2.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 11.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 13.9 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 14.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 4.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 16.1 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 7.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 1.1 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 1.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 180.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 4.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 3.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 2.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 1.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 3.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 28.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 1.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 2.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 4.5 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 2.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 3.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 6.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 11.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 3.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 11.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 2.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 25.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 15.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 3.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 4.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 2.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 3.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 41.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 10.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 4.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 2.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 1.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 1.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.2 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 7.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 5.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 60.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 16.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 35.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 4.8 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 11.7 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 3.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 4.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 2.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 5.7 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 4.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 1.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 14.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 16.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 11.5 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 8.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 13.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 11.7 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 16.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 8.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 3.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 22.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 4.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 13.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 5.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 4.3 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 7.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 4.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 61.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
11.3 | 56.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
6.2 | 18.7 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
5.2 | 15.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
4.8 | 14.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
4.1 | 20.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
4.0 | 28.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
3.3 | 9.9 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
3.0 | 38.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.8 | 11.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.7 | 8.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
2.7 | 16.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
2.6 | 26.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.6 | 10.4 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
2.6 | 10.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
2.5 | 33.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.5 | 15.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.4 | 11.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.2 | 28.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.2 | 8.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
2.1 | 6.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
2.0 | 6.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.0 | 8.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.0 | 21.7 | GO:0050700 | CARD domain binding(GO:0050700) |
2.0 | 7.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.9 | 7.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.9 | 5.7 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
1.9 | 5.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.9 | 16.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.9 | 14.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.9 | 48.4 | GO:0051400 | BH domain binding(GO:0051400) |
1.8 | 16.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.7 | 8.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.7 | 5.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.6 | 6.5 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) ceramide binding(GO:0097001) |
1.6 | 4.8 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
1.6 | 6.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.5 | 12.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 21.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.5 | 6.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.5 | 4.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.5 | 8.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.5 | 18.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.5 | 4.4 | GO:0035375 | zymogen binding(GO:0035375) |
1.4 | 10.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.4 | 12.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.4 | 5.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.3 | 3.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.3 | 5.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
1.3 | 5.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.3 | 20.3 | GO:0005522 | profilin binding(GO:0005522) |
1.2 | 3.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.2 | 6.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.2 | 5.9 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 3.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
1.1 | 26.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.1 | 19.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.1 | 10.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.1 | 4.4 | GO:0036033 | mediator complex binding(GO:0036033) |
1.1 | 4.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.1 | 62.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
1.1 | 59.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.1 | 14.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 9.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 16.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.0 | 6.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.0 | 5.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.0 | 2.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.9 | 40.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.9 | 31.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.9 | 8.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.9 | 4.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 2.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 5.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.9 | 23.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.9 | 2.8 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.9 | 16.5 | GO:0043495 | protein anchor(GO:0043495) |
0.9 | 22.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 2.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.9 | 22.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.9 | 2.7 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
0.9 | 28.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.9 | 10.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.9 | 2.6 | GO:0052600 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
0.9 | 9.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 2.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.8 | 9.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.8 | 4.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.8 | 21.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.8 | 4.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.8 | 44.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 10.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 3.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.8 | 3.8 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.8 | 7.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 6.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 2.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 2.2 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.7 | 3.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 5.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.7 | 5.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.7 | 7.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 52.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 4.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 5.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.7 | 8.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 14.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 3.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.7 | 1.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 7.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.7 | 10.7 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.7 | 6.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 10.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 2.0 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.6 | 14.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 16.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 8.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 3.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 3.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 4.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 2.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.6 | 15.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.6 | 33.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 8.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 5.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 14.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 4.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 4.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.6 | 5.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 3.2 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 9.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 0.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.5 | 18.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 10.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 6.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 5.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 81.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 8.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 10.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 6.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 8.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.5 | 16.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 13.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.5 | 6.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 8.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.5 | 2.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 2.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 4.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 3.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.5 | 2.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.5 | 1.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.5 | 2.7 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 1.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.5 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 3.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 70.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 1.7 | GO:0043532 | angiostatin binding(GO:0043532) |
0.4 | 1.7 | GO:0004335 | galactokinase activity(GO:0004335) |
0.4 | 2.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 1.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.4 | 1.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.4 | 3.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 10.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 3.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 8.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 13.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 11.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 138.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 4.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 5.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 8.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 1.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 3.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 3.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 3.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 3.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 20.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 4.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 12.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 2.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.3 | 8.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 15.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 20.9 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 1.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 3.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 21.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 2.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 10.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 3.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 16.9 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.3 | 2.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 24.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 8.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 1.8 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 3.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 48.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 2.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.3 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 6.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 3.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 2.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 7.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 26.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 14.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 17.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 2.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 5.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 8.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 11.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.7 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.2 | 2.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 6.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 2.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 6.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 2.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 24.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 4.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 3.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 3.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.8 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 2.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 5.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 3.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 6.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 23.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 3.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 2.9 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 6.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 1.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 3.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 14.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 3.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 2.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 5.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 1.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 4.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 10.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 6.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 3.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 4.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 2.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 3.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 1.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 3.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 8.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.5 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) transcription factor activity, core RNA polymerase III binding(GO:0000995) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.1 | 2.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 4.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 5.8 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 3.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 3.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 2.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 2.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 3.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 4.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 51.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 11.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 2.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.3 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
0.1 | 2.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 5.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 4.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 4.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 2.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 4.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 9.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 8.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 25.0 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 1.1 | GO:0001614 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 89.8 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 9.0 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 1.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 1.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 3.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 6.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 4.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 1.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0070815 | histone demethylase activity(GO:0032452) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 288.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.0 | 68.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.9 | 45.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.7 | 28.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.6 | 11.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.4 | 38.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.4 | 84.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.2 | 43.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 17.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 48.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.9 | 13.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.8 | 10.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 27.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 5.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 11.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.7 | 7.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 37.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 4.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 65.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 32.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.6 | 20.2 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 16.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.6 | 35.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.6 | 30.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 39.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 22.0 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 28.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 7.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 9.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 23.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 18.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 13.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 9.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 14.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 12.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 5.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 10.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 6.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 5.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 6.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 6.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 13.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 12.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 31.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 10.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 22.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 1.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 32.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 1.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 6.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 7.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 7.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 12.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 3.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 10.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 12.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 5.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 3.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 8.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 3.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 13.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 5.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 5.9 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 8.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 10.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 5.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 19.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 4.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 132.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
4.2 | 42.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.2 | 127.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.0 | 11.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.9 | 37.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.8 | 104.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.8 | 12.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.7 | 12.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.6 | 20.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.6 | 15.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.5 | 3.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.5 | 20.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.5 | 18.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.4 | 64.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.4 | 22.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.4 | 22.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.3 | 83.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 20.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.0 | 33.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.0 | 6.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.0 | 15.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 6.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 111.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.9 | 11.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.9 | 14.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.9 | 5.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.9 | 8.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.9 | 10.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.8 | 38.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.8 | 43.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 31.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 14.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.7 | 11.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.6 | 4.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.6 | 12.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 36.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 16.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.6 | 7.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 12.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 3.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 17.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 13.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 6.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 5.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 8.2 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.5 | 7.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 6.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 66.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 2.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.5 | 42.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.5 | 5.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 1.4 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.4 | 5.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 6.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 28.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 5.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 14.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 6.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 4.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 3.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 3.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 6.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 3.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 6.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 21.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 8.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 9.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 13.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 4.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 7.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 3.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 2.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 6.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 3.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 7.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 2.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 11.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 5.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 6.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 7.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.7 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 1.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 3.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 7.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 7.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 8.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 4.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 4.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 7.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 3.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 5.3 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 7.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 5.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 3.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 3.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 5.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 5.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 2.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 2.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |